Elanco Animal Health Incorporated
Elanco Animal Health Incorporated (ELAN) Revenue
Annual & quarterly revenue history · segment & region breakdown
ELAN · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsElanco Animal Health Incorporated trailing twelve-month (TTM) revenue is $4.89B, an increase of 6.22% year-over-year from $4.71B in FY2025.
Revenue trend
2025 – 2015 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $4.71B | +$0.28B | +6.22% |
| 2024-12-31 | $4.44B | +$0.02B | +0.50% |
| 2023-12-31 | $4.42B | +$0.01B | +0.14% |
| 2022-12-31 | $4.41B | -$0.35B | -7.41% |
| 2021-12-31 | $4.76B | +$1.49B | +45.54% |
| 2020-12-31 | $3.27B | +$0.20B | +6.59% |
| 2019-12-31 | $3.07B | +$0.00B | +0.14% |
| 2018-12-31 | $3.07B | +$0.18B | +6.15% |
| 2017-12-31 | $2.89B | -$0.02B | -0.84% |
| 2016-12-31 | $2.91B | +$0.00B | +0.15% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare ELAN revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Elanco Animal Health Incorporated receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Elanco Animal Health Incorporated reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Elanco Animal Health Incorporated's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ELAN revenue · 4 questionsELAN's trailing twelve-month (TTM) revenue is $4.89B. That is an increase of 6.22% year-over-year from $4.71B in FY2025.
▸ Source: FMP · Elanco Animal Health Incorporated SEC filings · GAAP · Elanco Animal Health Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026